Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk
GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
US:NYSE Investor Relations:
gsk.com/en-gb/investors
Company Research
Source: PR Newswire
Brooke Shields convenes other celebrities, influencers and patient advocates over 50 to discuss the power of aging and how to protect their healthShields directs a short film, encouraging adults 50 years of age and older to talk to their doctor or pharmacist about their risk for shingles — a disease that affects about 1 million people annually in the US — and about vaccinationThe partnership is part of GSK's national THRIVE@50+ campaignPHILADELPHIA, Sept. 16, 2024 /PRNewswire/ -- GSK plc (LSE/NYSE: GSK) is partnering with Brooke Shields, as part of its THRIVE@50+ campaign, to encourage people 50 and older to embrace and protect the power they've found in aging by asking their doctor or pharmacist about their risk for shingles and about vaccination.Experience the full interactive Multichannel News Release here: https://www2.multivu.com/gsk/9290451-en-brooke-shields-gsk-shingles-risk-adults-50-and-olderShields exemplifies what it means to thrive at any age, including now, at her current
Show less
Read more
Impact Snapshot
Event Time:
GSK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GSK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GSK alerts
High impacting GSK plc American Depositary Shares (Each representing two Ordinary Shares) news events
Weekly update
A roundup of the hottest topics
GSK
News
- GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIXBusiness Wire
- GSK plc (NYSE: GSK) was upgraded by analysts at Barclays PLC to a "hold" rating.MarketBeat
- GSK plc (GSK): A Cheap Pharmaceutical Stock to Buy According to Short Sellers [Yahoo! Finance]Yahoo! Finance
- GSK plc (GSK): Why Are Hedge Funds Bullish on This Undervalued UK Stock Now? [Yahoo! Finance]Yahoo! Finance
- GSK plc (NYSE: GSK) was upgraded by analysts at Argus to a "strong-buy" rating.MarketBeat
GSK
Sec Filings
- 9/18/24 - Form 6-K
- 9/17/24 - Form 6-K
- 9/13/24 - Form 6-K
- GSK's page on the SEC website